Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

CardioFocus brings in $30.6mm through its Series D venture round

Executive Summary

CardioFocus Inc. (atrial fibrillation transcatheter treatment) has raised $30.6mm through the closing of its Series D venture round. New backers Fletcher Spaght Ventures, Manatuck Hill Partners, and First Alliance & Capital Invest were joined by previous shareholders SV Life Sciences, HIG BioVentures, Accuitive Medical Ventures, the Aurora Funds, Oxford Bioscience Partners, Kestrel Venture Management, and KBL Healthcare Investors. The company will use the funds to continue marketing its endoscopic ablation system in Europe and begin a US IDE pivotal study.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register